About Endra Life Sciences
Endra Life Sciences is a company based in Ann Arbor (United States) founded in 2007. Endra Life Sciences has raised $287.1 thousand across 5 funding rounds. The company has 21 employees as of December 31, 2024. Endra Life Sciences offers products and services including TAEUS®.
- Headquarter Ann Arbor, United States
- Employees 21 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Endra Life Sciences Inc.
-
Annual Revenue
Not available
-
Net Profit
-$11.51 M (USD)-14.39as on Dec 31, 2024
-
EBITDA
-$17.93 M (USD)-75.05as on Dec 31, 2024
-
Total Equity Funding
$287.1 K (USD)
in 5 rounds
-
Latest Funding Round
$14.4 M (USD), Post-IPO
Oct 10, 2025
-
Investors
Not available
-
Employee Count
21
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Endra Life Sciences
Endra Life Sciences is a publicly listed company on the NASDAQ with ticker symbol NDRA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Endra Life Sciences
Endra Life Sciences offers a comprehensive portfolio of products and services, including TAEUS®.
Non-invasive ultrasound tool for measuring liver fat and detecting disease.
People of Endra Life Sciences
Unlock access to complete
Unlock access to complete
Funding Insights of Endra Life Sciences
Endra Life Sciences has successfully raised a total of $287.1K across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $14.4 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Endra Life Sciences
Investment portfolio details for Endra Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Endra Life Sciences
Detailed financials for Endra Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endra Life Sciences Comparisons
Peer comparison for Endra Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Endra Life Sciences
Detailed competitors of Endra Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endra Life Sciences
Complete news archive for Endra Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Endra Life Sciences
Endra Life Sciences was founded in 2007 and raised its 1st funding round 7 years after it was founded.
Endra Life Sciences is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Francois Michelon is the current CEO of Endra Life Sciences.
Endra Life Sciences is a funded company, having raised a total of $287.1K across 5 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Endra Life Sciences is 21.
Developer of ultrasound imaging technology for liver disease detection. The company offers Thermo-acoustic enhanced ultrasound (TAEUS) that uses radio frequency and ultrasound waves for deep tissue imaging and to measure fat in the liver which is the cause of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH).
Endra Life Sciences offers TAEUS®.
Yes, Endra Life Sciences is publicly traded on NASDAQ under the ticker symbol NDRA.
The ticker symbol of Endra Life Sciences is NDRA on NASDAQ.